Education
About Us
Working with TipRanks
Follow Us
Linical Co., Ltd. (JP:2183)
:2183
RESEARCH TOOLSreports
2183 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥258.00 - ¥449.00
Previous CloseN/A
Volume36.50K
Average Volume (3M)16.41K
Market Cap
¥7.52B
Enterprise Value¥12.24B
Total Cash (Recent Filing)¥6.77B
Total Debt (Recent Filing)¥2.43B
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Aug 14, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 28, 2025Dividend Yield4.8%
Share Statistics
EPS (TTM)-9.84
Shares Outstanding24,740,000
10 Day Avg. Volume14,590
30 Day Avg. Volume16,410
Financial Highlights & Ratios
PEG Ratio0.58
Price to Book (P/B)2.08
Price to Sales (P/S)0.00
P/FCF Ratio8.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥311.00Price Target Upside-6.89% Downside
Rating ConsensusHold
Number of Analyst Covering0
Linical Co., Ltd. News
PremiumCompany Announcements
Linical Co., Ltd. Announces Year-End Dividend Distribution
PremiumCompany Announcements
Linical Revises Fiscal Forecast Amid Global Challenges, Records Tax Gain
PremiumCompany Announcements
Linical Reports Decline in Financial Performance for 2024
PremiumCompany Announcements
Linical Revises Financial Forecast Amid Global ChallengesPremiumCompany Announcements
Linical Co., Ltd. Reports Decline in 2024 Financial Performance
PremiumCompany Announcements
Linical Co. Faces Q1 Sales Dip Amid Market ContrastsPremiumCompany Announcements
Linical Co. Faces Q1 Downturn but Forecasts Strong YearOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
2183 FAQ
What was Linical Co., Ltd.’s price range in the past 12 months?
Linical Co., Ltd. lowest stock price was ¥258.00 and its highest was ¥449.00 in the past 12 months.
What is Linical Co., Ltd.’s market cap?
Linical Co., Ltd.’s market cap is ¥7.52B.
When is Linical Co., Ltd.’s upcoming earnings report date?
Linical Co., Ltd.’s upcoming earnings report date is Aug 14, 2025 which is in 26 days.
How were Linical Co., Ltd.’s earnings last quarter?
Linical Co., Ltd. released its earnings results on May 15, 2025. The company reported -¥9.84 earnings per share for the quarter, missing the consensus estimate of N/A by -¥9.84.
Is Linical Co., Ltd. overvalued?
According to Wall Street analysts Linical Co., Ltd.’s price is currently Overvalued.
Does Linical Co., Ltd. pay dividends?
Linical Co., Ltd. pays a Annually dividend of ¥16 which represents an annual dividend yield of 4.8%. See more information on Linical Co., Ltd. dividends here
What is Linical Co., Ltd.’s EPS estimate?
Linical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Linical Co., Ltd. have?
Linical Co., Ltd. has 24,740,000 shares outstanding.
What happened to Linical Co., Ltd.’s price movement after its last earnings report?
Linical Co., Ltd. reported an EPS of -¥9.84 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.334%.
Which hedge fund is a major shareholder of Linical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:2183
Company Description
Linical Co., Ltd.
Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Technical Analysis
OncoTherapy Science
―
Cytori Cell Research Institute, Inc.
―
Kidswell Bio Corporation
―
TMS Co., Ltd.
―
Noile-Immune Biotech Inc.
―